Mihály Józsi Selected Research

Mihály Józsi Research Topics

Disease

18	Atypical Hemolytic Uremic Syndrome 01/2021 - 01/2006
10	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021 - 01/2006
7	Infections 01/2021 - 11/2003
6	Kidney Diseases (Kidney Disease) 01/2021 - 09/2007
6	Hemolytic-Uremic Syndrome 01/2019 - 01/2006
6	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2006
5	Inflammation (Inflammations) 01/2022 - 02/2007
5	Hemolysis 01/2017 - 02/2007
3	Thrombotic Thrombocytopenic Purpura 01/2019 - 11/2003
2	Neoplasms (Cancer) 12/2019 - 10/2019
2	Communicable Diseases (Infectious Diseases) 10/2019 - 08/2008
2	Glomerulonephritis 01/2019 - 01/2017
2	Hypersensitivity (Allergy) 03/2018 - 05/2016
2	Eye Diseases (Eye Disease) 02/2012 - 01/2006
2	Acute Kidney Injury (Acute Renal Failure) 01/2012 - 02/2007
1	Amyloidosis 11/2021
1	COVID-19 01/2021
1	Neuromyelitis Optica (Devic's Disease) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Thrombotic Microangiopathies 01/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2018
1	Convalescence 01/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 04/2016
1	Edema (Dropsy) 12/2015
1	Paraproteinemias (Monoclonal Gammopathy) 04/2012
1	Leptospirosis 03/2012
1	Thrombosis (Thrombus) 09/2009
1	Sepsis (Septicemia) 01/2009
1	Thrombocytopenia (Thrombopenia) 02/2007
1	Immune System Diseases (Immune Disorders) 01/2006

Drug/Important Bio-Agent (IBA)

31	Complement System Proteins (Complement)IBA 01/2021 - 11/2003
18	Complement Factor H (Factor H)IBA 01/2021 - 01/2006
16	AutoantibodiesIBA 01/2021 - 09/2007
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
3	LigandsIBA 01/2022 - 02/2012
3	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 04/2010
3	EpitopesIBA 01/2017 - 04/2015
3	factor H-related protein 1IBA 04/2015 - 08/2011
2	thiamine triphosphorate (TTP)IBA 01/2019 - 09/2009
2	Monoclonal AntibodiesIBA 03/2018 - 01/2017
2	Complement Factor B (Factor B)IBA 01/2012 - 04/2010
2	A-factor (Streptomyces)IBA 08/2011 - 02/2007
1	Aquaporins (Water Channels)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	VaccinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Aquaporin 4IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 12/2019
1	N 30IBA 01/2019
1	Complement C3 (C3 Complement)IBA 01/2019
1	EnzymesIBA 03/2018
1	Contrast MediaIBA 03/2018
1	Peptides (Polypeptides)IBA 01/2017
1	Arginine (L-Arginine)FDA Link 01/2017
1	Tryptophan (L-Tryptophan)FDA Link 01/2017
1	Amino Acids FDA Link 01/2017
1	Drug CarriersIBA 05/2016
1	MicellesIBA 05/2016
1	Liposomes (Liposome)IBA 05/2016
1	eculizumab FDA Link 04/2016
1	Complement Inactivating AgentsIBA 04/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2015
1	AntibodiesIBA 06/2014
1	Biological ProductsIBA 01/2014
1	PTX3 proteinIBA 08/2012
1	DNA (Deoxyribonucleic Acid)IBA 02/2012
1	Extracellular Matrix ProteinsIBA 02/2012
1	Immunoglobulin G (IgG)IBA 08/2011
1	Mutant Proteins (Protein, Mutant)IBA 02/2007
1	ADAMTS13 ProteinIBA 11/2003

Therapy/Procedure

2	Therapeutics 01/2021 - 04/2016